Cypress Bioscience

Exagen will pay Cypress up to $8 million in upfront and milestone payments as well as additional royalty payments for the business.

Under the deal, Marina will receive $750,000 up front, and stands to be paid as much as $27 million in milestones.

The firm offers its Avise PG test as a service for physicians making decisions about methotrexate therapy.

Cypress will pay up to $5 million for the technology, which it plans to use for diagnosis and therapeutic monitoring of lupus patients.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.